KromaTiD Announces Closing of Series A Round

June 26, 2017

KromaTiD, the provider of Directional Genomic Hybridization and Pinpoint FISH products, successfully completed its Series A round as of May 31st, 2017. Funds from this round will be used to grow sales and expand marketing of KromaTiD’s proprietary products and services, as well as building operations to meet market demand for precision medicine products.